SURVYR

HCA

HCA Healthcare, Inc.
$449.96
−$15.30 (3.29%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-24%-13%-2%+9%+20%Oct 2025Oct 2026Apr 202652w high $556.5252w low $353.99
HCASPY
Wall St. Highest PT $579.00 (+28.7%) Wall St. Avg PT $461.81 (+2.6%)
$360$429$498$567$637POC $471Hi $579Avg $462
Underwater Drawdown %Max DD -33.6%Current -17.0%
0.0%-33.6%
Relative Strength vs SPY-16.7% vs SPYUnderperforming
+39%0%-39%
1W
−$15.79 (3.39%)
1M
+$14.35 (3.29%)
3M
+$32.54 (7.80%)
6M
+$19.70 (4.58%)
YTD
−$14.42 (3.10%)
1Y
−$14.72 (3.17%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
26 analysts · mean score 2.00
1 = Strong Buy · 5 = Sell
Strong Buy14%
Buy1454%
Hold935%
Underperform14%
Sell14%
Wall Street consensus
Analyst price targets
Current price$449.96
Average target$461.81
+$11.85 (+2.6%) upsideaverage target vs current price
CurrentAverageMedian
Low$380.00
Median$476.00
High$579.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-12 · TD Cowen reiterated Buy on HCA
Reiterated
2026-10-07 · RBC Capital reiterated Outperform on HCA
Initiated
2026-09-23 · BMO Capital started covering HCA at Outperform
Reiterated
2026-09-18 · Leerink Partners reiterated Outperform on HCA
Reiterated
2026-09-08 · RBC Capital reiterated Outperform on HCA
Reiterated
2026-08-20 · JP Morgan reiterated Neutral on HCA
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$97.4B
P/E (last 12 months)15.1
P/E (next 12 months, estimated)14.1
52-week range$353.99 – $556.52
Revenue growth (latest quarter vs a year ago)+8.7%
Dividend yield0.67%
Analyst consensusBuy (21)
Average analyst price target$461.81 (+3%)

What they do

HCA Healthcare, Inc. provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
24th percentile in sector
D+
12-1 return: -6.5%
Percentile within its GICS sector across the S&P 1500.
Growth
51st percentile in sector
C+
Revenue growth (YoY): +8.7%
Percentile within its GICS sector across the S&P 1500.
Value
74th percentile in sector
B+
Forward E/P: 7.0% · EBITDA/EV: 10.3%
Percentile within its GICS sector across the S&P 1500.
Profitability
55th percentile in sector
C+
Profit margin: +8.8% · Return on equity: –
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 351 of 499 · 12-month momentum -2.3%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

HCA earningsReported Oct 27, 2026▲ Above estimates
Results · Before the open
EPS actual$7.22
EPS estimate$6.63
Surprise+8.9%
RevenueNot in our data yet

Revenue for this quarter is not in our data yet. It arrives with the quarterly filing.

Next report · quarter Sep 2026
Tue Oct 27, 2026Before the open
EPS consensus$8.06 range $7.57–$8.61
Revenue consensus$20.0B 14 analysts
Last 4 quarters · EPS vs estimate
Oct 27, 2026$7.22est $6.63+8.9%Above estimates
Jul 24, 2026$7.59est $7.50+1.2%Above estimates
Apr 24, 2026$7.15est $7.13+0.3%In line with estimates
Jan 27, 2026$8.01est $7.48+7.1%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:24:14 ET
25-0125-0425-0725-1026-0126-0426-0726-100.008.01
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$20.2B+8.7%
2026-03-31$19.1B–
2025-12-31$19.5B–
2025-09-30$19.2B–
2025-06-30$18.6B–

Recent dividends

2026-09-16: $0.780 · 2026-06-16: $0.780 · 2026-03-17: $0.780 · 2025-12-15: $0.720 · 2025-09-16: $0.720 · 2025-06-16: $0.720 · 2025-03-17: $0.720 · 2024-12-13: $0.660

News & catalysts

More news
HCA (HCA) Q3 2026 Earnings Call Transcript
Nasdaq · 12h ago
HCA signals flat 2027 earnings as Medicaid payments drop; shares slide
Investing.com · 12h ago
HCA Healthcare Sickens Hospital Stocks With 2027 Outlook
Investor's Business Daily · 13h ago
Why is HCA Healthcare stock surging today?
Investing.com · 19h ago
HCA Healthcare (HCA) files 8-K: results, Reg FD disclosure, other event
SEC 8-K · 19h ago
Rating changes
Reiterated
2026-10-12 · TD Cowen reiterated Buy on HCA
Reiterated
2026-10-07 · RBC Capital reiterated Outperform on HCA
Initiated
2026-09-23 · BMO Capital started covering HCA at Outperform
Reiterated
2026-09-18 · Leerink Partners reiterated Outperform on HCA
Reiterated
2026-09-08 · RBC Capital reiterated Outperform on HCA
Reiterated
2026-08-20 · JP Morgan reiterated Neutral on HCA

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:24:14 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026